Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Testosterone | 87 | 2024 | 2495 | 5.770 |
Why?
|
Delirium | 37 | 2024 | 1698 | 2.800 |
Why?
|
Androgens | 31 | 2023 | 1280 | 2.630 |
Why?
|
Hypogonadism | 16 | 2024 | 802 | 2.410 |
Why?
|
Mobility Limitation | 25 | 2023 | 409 | 2.320 |
Why?
|
Sex Hormone-Binding Globulin | 21 | 2024 | 557 | 2.240 |
Why?
|
Muscle Strength | 18 | 2023 | 639 | 1.750 |
Why?
|
Sarcopenia | 11 | 2021 | 378 | 1.660 |
Why?
|
Erectile Dysfunction | 12 | 2024 | 437 | 1.590 |
Why?
|
Accidental Falls | 16 | 2021 | 1078 | 1.570 |
Why?
|
Body Composition | 25 | 2024 | 2441 | 1.520 |
Why?
|
Hand Strength | 12 | 2020 | 464 | 1.520 |
Why?
|
Aging | 35 | 2024 | 8731 | 1.480 |
Why?
|
Estradiol | 16 | 2024 | 1947 | 1.410 |
Why?
|
Hormone Replacement Therapy | 15 | 2024 | 751 | 1.410 |
Why?
|
Estrone | 9 | 2018 | 234 | 1.380 |
Why?
|
Geriatric Assessment | 16 | 2023 | 1422 | 1.060 |
Why?
|
Androgen Antagonists | 7 | 2024 | 1411 | 1.020 |
Why?
|
Walking | 9 | 2021 | 1201 | 0.990 |
Why?
|
Gait | 13 | 2023 | 823 | 0.960 |
Why?
|
Aged | 184 | 2024 | 171343 | 0.900 |
Why?
|
Muscle, Skeletal | 15 | 2024 | 4970 | 0.860 |
Why?
|
Postural Balance | 10 | 2020 | 637 | 0.860 |
Why?
|
Independent Living | 18 | 2023 | 584 | 0.840 |
Why?
|
Frail Elderly | 5 | 2023 | 781 | 0.730 |
Why?
|
Recovery of Function | 6 | 2020 | 2976 | 0.710 |
Why?
|
Gait Disorders, Neurologic | 2 | 2021 | 244 | 0.680 |
Why?
|
Muscle Weakness | 6 | 2020 | 412 | 0.670 |
Why?
|
Bone Density | 14 | 2018 | 3491 | 0.670 |
Why?
|
Phosphodiesterase 5 Inhibitors | 4 | 2013 | 103 | 0.650 |
Why?
|
Male | 199 | 2024 | 364142 | 0.650 |
Why?
|
Prediabetic State | 1 | 2024 | 547 | 0.600 |
Why?
|
Femur | 3 | 2008 | 1318 | 0.570 |
Why?
|
Diagnostic Techniques, Endocrine | 1 | 2017 | 43 | 0.550 |
Why?
|
Gonadal Steroid Hormones | 5 | 2023 | 706 | 0.550 |
Why?
|
Postoperative Complications | 23 | 2024 | 15831 | 0.540 |
Why?
|
Insulin Resistance | 8 | 2024 | 3989 | 0.540 |
Why?
|
Dementia | 7 | 2022 | 2741 | 0.540 |
Why?
|
Aged, 80 and over | 66 | 2024 | 59550 | 0.520 |
Why?
|
Humans | 241 | 2024 | 766766 | 0.520 |
Why?
|
Patient Readmission | 6 | 2021 | 3283 | 0.510 |
Why?
|
Luteinizing Hormone | 8 | 2024 | 828 | 0.490 |
Why?
|
Prospective Studies | 55 | 2024 | 54871 | 0.470 |
Why?
|
Hip Fractures | 4 | 2020 | 996 | 0.470 |
Why?
|
Prostatic Neoplasms | 8 | 2024 | 11094 | 0.470 |
Why?
|
Double-Blind Method | 32 | 2024 | 12430 | 0.450 |
Why?
|
Exercise | 8 | 2020 | 5945 | 0.450 |
Why?
|
Vascular Cell Adhesion Molecule-1 | 4 | 2018 | 692 | 0.440 |
Why?
|
Cross-Sectional Studies | 40 | 2024 | 26310 | 0.440 |
Why?
|
Longitudinal Studies | 23 | 2023 | 14762 | 0.440 |
Why?
|
Genes, Y-Linked | 1 | 2013 | 12 | 0.440 |
Why?
|
Cerebrovascular Circulation | 4 | 2017 | 2672 | 0.430 |
Why?
|
Pacemaker, Artificial | 2 | 2017 | 828 | 0.430 |
Why?
|
Malnutrition | 1 | 2020 | 629 | 0.420 |
Why?
|
Middle Aged | 100 | 2024 | 223257 | 0.420 |
Why?
|
Research Design | 8 | 2024 | 6207 | 0.410 |
Why?
|
Activities of Daily Living | 8 | 2023 | 2429 | 0.400 |
Why?
|
Kyphosis | 4 | 2019 | 252 | 0.390 |
Why?
|
Analgesics, Opioid | 8 | 2022 | 3837 | 0.390 |
Why?
|
Absorptiometry, Photon | 13 | 2021 | 1707 | 0.390 |
Why?
|
Andropause | 2 | 2008 | 8 | 0.380 |
Why?
|
Motor Activity | 2 | 2012 | 2711 | 0.380 |
Why?
|
Dietary Proteins | 5 | 2021 | 960 | 0.370 |
Why?
|
Models, Statistical | 3 | 2020 | 5091 | 0.370 |
Why?
|
Dihydrotestosterone | 4 | 2024 | 194 | 0.370 |
Why?
|
Ataxia | 3 | 2017 | 307 | 0.350 |
Why?
|
Dietary Supplements | 7 | 2020 | 3429 | 0.350 |
Why?
|
Retinoscopy | 1 | 2010 | 27 | 0.350 |
Why?
|
Chromatography, Liquid | 6 | 2013 | 996 | 0.340 |
Why?
|
Cardiovascular Diseases | 18 | 2024 | 15657 | 0.340 |
Why?
|
Body Mass Index | 19 | 2024 | 13050 | 0.330 |
Why?
|
Arrhythmias, Cardiac | 2 | 2017 | 2258 | 0.330 |
Why?
|
Female | 109 | 2024 | 396520 | 0.320 |
Why?
|
Thoracic Vertebrae | 3 | 2019 | 613 | 0.310 |
Why?
|
Refraction, Ocular | 1 | 2010 | 188 | 0.310 |
Why?
|
Consensus | 5 | 2020 | 3208 | 0.300 |
Why?
|
Refractive Errors | 1 | 2010 | 148 | 0.300 |
Why?
|
Weight Loss | 3 | 2016 | 2712 | 0.300 |
Why?
|
Life Style | 6 | 2024 | 3926 | 0.290 |
Why?
|
Boston | 18 | 2023 | 9346 | 0.290 |
Why?
|
Alzheimer Disease | 7 | 2024 | 8717 | 0.290 |
Why?
|
Cohort Studies | 27 | 2024 | 41710 | 0.290 |
Why?
|
Gastric Bypass | 1 | 2016 | 820 | 0.290 |
Why?
|
Tandem Mass Spectrometry | 6 | 2013 | 1197 | 0.280 |
Why?
|
Defibrillators, Implantable | 1 | 2017 | 1499 | 0.280 |
Why?
|
Cognition | 12 | 2023 | 7057 | 0.280 |
Why?
|
Antihypertensive Agents | 2 | 2023 | 2030 | 0.270 |
Why?
|
Hysterectomy | 3 | 2019 | 863 | 0.270 |
Why?
|
Intra-Abdominal Fat | 2 | 2023 | 624 | 0.270 |
Why?
|
Adult | 71 | 2024 | 223307 | 0.270 |
Why?
|
Sulfones | 3 | 2013 | 447 | 0.260 |
Why?
|
Femur Neck | 5 | 2018 | 316 | 0.260 |
Why?
|
Massachusetts | 11 | 2022 | 8891 | 0.260 |
Why?
|
Cognition Disorders | 5 | 2018 | 3967 | 0.250 |
Why?
|
Libido | 1 | 2006 | 123 | 0.250 |
Why?
|
Risk Factors | 38 | 2024 | 74881 | 0.250 |
Why?
|
Health Status | 8 | 2018 | 4087 | 0.240 |
Why?
|
Fontan Procedure | 4 | 2012 | 805 | 0.240 |
Why?
|
Obesity, Morbid | 1 | 2016 | 1292 | 0.240 |
Why?
|
Tai Ji | 2 | 2019 | 289 | 0.240 |
Why?
|
Age Factors | 16 | 2024 | 18397 | 0.230 |
Why?
|
Quality of Life | 13 | 2023 | 13476 | 0.230 |
Why?
|
Remission, Spontaneous | 3 | 2011 | 384 | 0.220 |
Why?
|
Geriatric Nursing | 2 | 2021 | 39 | 0.220 |
Why?
|
Leg Injuries | 4 | 2007 | 180 | 0.220 |
Why?
|
Physicians | 1 | 2022 | 4591 | 0.220 |
Why?
|
Disability Evaluation | 4 | 2020 | 1827 | 0.220 |
Why?
|
Interleukin-6 | 3 | 2024 | 3227 | 0.210 |
Why?
|
Atrophy | 3 | 2024 | 1631 | 0.210 |
Why?
|
Erythropoietin | 3 | 2018 | 718 | 0.210 |
Why?
|
Prevalence | 12 | 2020 | 15835 | 0.210 |
Why?
|
5-alpha Reductase Inhibitors | 2 | 2016 | 112 | 0.210 |
Why?
|
Incidence | 14 | 2024 | 21525 | 0.210 |
Why?
|
Biostatistics | 1 | 2024 | 162 | 0.210 |
Why?
|
Urinary Retention | 1 | 2023 | 100 | 0.210 |
Why?
|
Socioeconomic Factors | 8 | 2024 | 7841 | 0.210 |
Why?
|
Fluoroimmunoassay | 2 | 2013 | 30 | 0.210 |
Why?
|
Severity of Illness Index | 12 | 2023 | 15908 | 0.210 |
Why?
|
Fractures, Bone | 4 | 2022 | 2043 | 0.200 |
Why?
|
Hospitalization | 11 | 2022 | 10823 | 0.200 |
Why?
|
Erythropoiesis | 2 | 2018 | 692 | 0.200 |
Why?
|
Exercise Test | 5 | 2020 | 2188 | 0.200 |
Why?
|
Psychometrics | 4 | 2022 | 3060 | 0.200 |
Why?
|
Adipose Tissue | 3 | 2023 | 3314 | 0.200 |
Why?
|
Follow-Up Studies | 18 | 2019 | 39309 | 0.190 |
Why?
|
Ergocalciferols | 2 | 2013 | 105 | 0.190 |
Why?
|
Administration, Cutaneous | 7 | 2020 | 712 | 0.190 |
Why?
|
Oxygen Consumption | 3 | 2018 | 1874 | 0.190 |
Why?
|
Liver | 4 | 2024 | 7571 | 0.190 |
Why?
|
Logistic Models | 12 | 2020 | 13278 | 0.190 |
Why?
|
Health Education | 2 | 2019 | 1060 | 0.190 |
Why?
|
Polycythemia | 2 | 2013 | 124 | 0.180 |
Why?
|
Reference Values | 7 | 2017 | 4913 | 0.180 |
Why?
|
Depression | 8 | 2024 | 8228 | 0.180 |
Why?
|
Loneliness | 1 | 2023 | 211 | 0.180 |
Why?
|
Physical Fitness | 3 | 2020 | 743 | 0.180 |
Why?
|
Estrogens | 3 | 2012 | 1528 | 0.180 |
Why?
|
Lower Extremity | 3 | 2019 | 1217 | 0.170 |
Why?
|
C-Reactive Protein | 3 | 2024 | 3853 | 0.170 |
Why?
|
Vitamin D | 6 | 2018 | 3270 | 0.170 |
Why?
|
Cerebral Cortex | 3 | 2024 | 5753 | 0.170 |
Why?
|
Affect | 3 | 2018 | 1494 | 0.170 |
Why?
|
Multivariate Analysis | 11 | 2017 | 12064 | 0.170 |
Why?
|
Randomized Controlled Trials as Topic | 6 | 2024 | 10384 | 0.170 |
Why?
|
Geriatrics | 1 | 2024 | 394 | 0.170 |
Why?
|
Confidence Intervals | 6 | 2011 | 2921 | 0.170 |
Why?
|
Baltimore | 1 | 2020 | 233 | 0.170 |
Why?
|
Aspirin | 2 | 2022 | 3135 | 0.170 |
Why?
|
Health Surveys | 7 | 2020 | 4055 | 0.170 |
Why?
|
Gels | 5 | 2023 | 420 | 0.160 |
Why?
|
Polymorphism, Genetic | 1 | 2010 | 4249 | 0.160 |
Why?
|
Antimicrobial Cationic Peptides | 2 | 2013 | 350 | 0.160 |
Why?
|
Dose-Response Relationship, Drug | 10 | 2019 | 10745 | 0.160 |
Why?
|
3-Oxo-5-alpha-Steroid 4-Dehydrogenase | 2 | 2017 | 74 | 0.160 |
Why?
|
Bone Remodeling | 2 | 2017 | 577 | 0.160 |
Why?
|
Risk Assessment | 14 | 2021 | 24295 | 0.160 |
Why?
|
Nurse's Role | 1 | 2020 | 187 | 0.160 |
Why?
|
Treatment Outcome | 24 | 2024 | 65273 | 0.160 |
Why?
|
Hydrocortisone | 1 | 2007 | 1838 | 0.160 |
Why?
|
Leuprolide | 2 | 2018 | 310 | 0.160 |
Why?
|
Osteoporosis | 3 | 2018 | 1581 | 0.160 |
Why?
|
Placebos | 5 | 2018 | 1659 | 0.160 |
Why?
|
Health Services for the Aged | 1 | 2021 | 264 | 0.150 |
Why?
|
Medication Reconciliation | 1 | 2020 | 153 | 0.150 |
Why?
|
Leg | 1 | 2023 | 1087 | 0.150 |
Why?
|
Nursing Homes | 3 | 2022 | 1084 | 0.150 |
Why?
|
Piperazines | 3 | 2013 | 2547 | 0.150 |
Why?
|
Lumbar Vertebrae | 4 | 2019 | 1878 | 0.150 |
Why?
|
Radius | 3 | 2011 | 441 | 0.150 |
Why?
|
Eunuchism | 1 | 2017 | 19 | 0.150 |
Why?
|
Aromatase | 1 | 2018 | 147 | 0.140 |
Why?
|
Europe | 2 | 2017 | 3430 | 0.140 |
Why?
|
Receptors, Androgen | 3 | 2016 | 1089 | 0.140 |
Why?
|
Agrin | 1 | 2017 | 75 | 0.140 |
Why?
|
Disease Progression | 8 | 2018 | 13640 | 0.140 |
Why?
|
Neuropsychological Tests | 7 | 2020 | 7119 | 0.140 |
Why?
|
Patient Care Management | 1 | 2020 | 302 | 0.140 |
Why?
|
Confusion | 2 | 2016 | 278 | 0.140 |
Why?
|
Pharmacoepidemiology | 1 | 2020 | 351 | 0.140 |
Why?
|
Ankle | 1 | 2020 | 353 | 0.140 |
Why?
|
Predictive Value of Tests | 9 | 2020 | 15416 | 0.140 |
Why?
|
Fatty Acid-Binding Proteins | 1 | 2018 | 292 | 0.130 |
Why?
|
Wounds and Injuries | 3 | 2018 | 2513 | 0.130 |
Why?
|
Reference Standards | 2 | 2017 | 1010 | 0.130 |
Why?
|
Prostatectomy | 1 | 2024 | 1786 | 0.130 |
Why?
|
Antineoplastic Agents, Hormonal | 3 | 2023 | 1536 | 0.130 |
Why?
|
Gonadotrophs | 1 | 2016 | 19 | 0.130 |
Why?
|
Long-Term Care | 1 | 2020 | 630 | 0.130 |
Why?
|
Public Housing | 1 | 2017 | 140 | 0.130 |
Why?
|
Cause of Death | 2 | 2024 | 3716 | 0.130 |
Why?
|
Spinal Curvatures | 1 | 2016 | 74 | 0.130 |
Why?
|
Pain Perception | 1 | 2017 | 197 | 0.130 |
Why?
|
Finasteride | 1 | 2016 | 86 | 0.130 |
Why?
|
Mental Health | 3 | 2023 | 3270 | 0.130 |
Why?
|
Endocrine System Diseases | 2 | 2008 | 247 | 0.120 |
Why?
|
Reproducibility of Results | 8 | 2022 | 20144 | 0.120 |
Why?
|
Time Factors | 13 | 2024 | 40149 | 0.120 |
Why?
|
Motor Skills | 1 | 2018 | 519 | 0.120 |
Why?
|
Mortality | 3 | 2020 | 2910 | 0.120 |
Why?
|
Resistance Training | 1 | 2017 | 197 | 0.120 |
Why?
|
Inflammation | 6 | 2024 | 10860 | 0.120 |
Why?
|
Craniocerebral Trauma | 1 | 2019 | 493 | 0.120 |
Why?
|
Blood Chemical Analysis | 1 | 2017 | 434 | 0.120 |
Why?
|
Accidents, Home | 1 | 2015 | 73 | 0.120 |
Why?
|
Clinical Laboratory Techniques | 1 | 2020 | 746 | 0.120 |
Why?
|
Magnetic Resonance Imaging | 13 | 2024 | 36567 | 0.120 |
Why?
|
Sexual Dysfunctions, Psychological | 1 | 2016 | 193 | 0.120 |
Why?
|
Videoconferencing | 1 | 2017 | 209 | 0.120 |
Why?
|
Heart Defects, Congenital | 4 | 2012 | 4712 | 0.120 |
Why?
|
Sensory Aids | 1 | 2014 | 40 | 0.120 |
Why?
|
Institutionalization | 1 | 2015 | 108 | 0.120 |
Why?
|
United States | 18 | 2022 | 72951 | 0.120 |
Why?
|
Inheritance Patterns | 1 | 2016 | 345 | 0.110 |
Why?
|
Cardiovascular System | 1 | 2021 | 839 | 0.110 |
Why?
|
Orthopedic Procedures | 3 | 2020 | 1279 | 0.110 |
Why?
|
Shoes | 1 | 2014 | 91 | 0.110 |
Why?
|
Patients | 1 | 2020 | 908 | 0.110 |
Why?
|
Vascular Resistance | 1 | 2017 | 939 | 0.110 |
Why?
|
Anemia | 1 | 2023 | 1514 | 0.110 |
Why?
|
Football | 1 | 2019 | 504 | 0.110 |
Why?
|
Motor Cortex | 1 | 2021 | 1004 | 0.110 |
Why?
|
Health Services Research | 1 | 2021 | 1811 | 0.110 |
Why?
|
Diet Records | 1 | 2015 | 425 | 0.110 |
Why?
|
Spleen | 2 | 2017 | 2295 | 0.110 |
Why?
|
Catastrophization | 1 | 2017 | 352 | 0.110 |
Why?
|
Young Adult | 14 | 2024 | 59939 | 0.110 |
Why?
|
Analgesics | 1 | 2020 | 1068 | 0.110 |
Why?
|
Glucose | 2 | 2024 | 4340 | 0.110 |
Why?
|
Nutrition Assessment | 1 | 2017 | 739 | 0.110 |
Why?
|
Comorbidity | 6 | 2019 | 10580 | 0.110 |
Why?
|
Health Care Costs | 3 | 2022 | 3242 | 0.110 |
Why?
|
Follicle Stimulating Hormone | 2 | 2016 | 731 | 0.110 |
Why?
|
Prostate | 3 | 2023 | 1757 | 0.110 |
Why?
|
Interview, Psychological | 1 | 2016 | 810 | 0.110 |
Why?
|
Aorta, Abdominal | 1 | 2016 | 627 | 0.100 |
Why?
|
Self Report | 2 | 2022 | 3771 | 0.100 |
Why?
|
Telephone | 1 | 2016 | 629 | 0.100 |
Why?
|
Sexual Dysfunction, Physiological | 3 | 2016 | 364 | 0.100 |
Why?
|
Cytokines | 2 | 2018 | 7438 | 0.100 |
Why?
|
Limb Salvage | 2 | 2008 | 488 | 0.100 |
Why?
|
Monitoring, Ambulatory | 1 | 2016 | 357 | 0.100 |
Why?
|
Body Height | 2 | 2010 | 1562 | 0.100 |
Why?
|
Models, Biological | 2 | 2011 | 9461 | 0.100 |
Why?
|
Vibration | 1 | 2014 | 334 | 0.100 |
Why?
|
25-Hydroxyvitamin D 2 | 1 | 2012 | 38 | 0.100 |
Why?
|
Sexuality | 1 | 2014 | 179 | 0.100 |
Why?
|
Models, Chemical | 1 | 2014 | 607 | 0.100 |
Why?
|
Body Weight | 5 | 2013 | 4626 | 0.100 |
Why?
|
Angiotensin II Type 1 Receptor Blockers | 1 | 2015 | 428 | 0.100 |
Why?
|
Heart Bypass, Right | 1 | 2012 | 75 | 0.100 |
Why?
|
Noise | 1 | 2014 | 296 | 0.100 |
Why?
|
Azasteroids | 1 | 2012 | 37 | 0.100 |
Why?
|
Alopecia | 1 | 2016 | 416 | 0.100 |
Why?
|
Length of Stay | 5 | 2020 | 6490 | 0.100 |
Why?
|
Diuretics | 1 | 2015 | 614 | 0.100 |
Why?
|
Diabetes Mellitus | 3 | 2023 | 5887 | 0.100 |
Why?
|
Postoperative Care | 2 | 2016 | 1480 | 0.100 |
Why?
|
Calcium Channel Blockers | 1 | 2015 | 687 | 0.100 |
Why?
|
Blood Glucose | 4 | 2021 | 6422 | 0.100 |
Why?
|
Regional Blood Flow | 1 | 2015 | 1478 | 0.100 |
Why?
|
Adiposity | 2 | 2012 | 1892 | 0.100 |
Why?
|
Calcifediol | 1 | 2012 | 156 | 0.090 |
Why?
|
Caregivers | 2 | 2021 | 2303 | 0.090 |
Why?
|
Calcitriol | 1 | 2013 | 301 | 0.090 |
Why?
|
Bone Density Conservation Agents | 1 | 2018 | 791 | 0.090 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2021 | 2270 | 0.090 |
Why?
|
Diet Surveys | 1 | 2015 | 1159 | 0.090 |
Why?
|
Dyslipidemias | 1 | 2018 | 872 | 0.090 |
Why?
|
Anabolic Agents | 1 | 2013 | 256 | 0.090 |
Why?
|
Chemistry, Clinical | 1 | 2011 | 64 | 0.090 |
Why?
|
Radius Fractures | 1 | 2017 | 515 | 0.090 |
Why?
|
Atherosclerosis | 2 | 2018 | 3420 | 0.090 |
Why?
|
Ankle Brachial Index | 1 | 2011 | 163 | 0.090 |
Why?
|
Vitamin D Deficiency | 2 | 2012 | 1349 | 0.090 |
Why?
|
Physical Therapy Modalities | 1 | 2014 | 533 | 0.090 |
Why?
|
Optometry | 1 | 2010 | 29 | 0.090 |
Why?
|
Testis | 1 | 2013 | 786 | 0.090 |
Why?
|
Executive Function | 2 | 2018 | 1396 | 0.080 |
Why?
|
Continuity of Patient Care | 1 | 2017 | 1077 | 0.080 |
Why?
|
Accommodation, Ocular | 1 | 2010 | 47 | 0.080 |
Why?
|
Impotence, Vasculogenic | 1 | 2009 | 13 | 0.080 |
Why?
|
Isoflavones | 1 | 2010 | 139 | 0.080 |
Why?
|
Aorta, Thoracic | 1 | 2016 | 1110 | 0.080 |
Why?
|
Protein Multimerization | 1 | 2014 | 960 | 0.080 |
Why?
|
Fatigue | 2 | 2018 | 1555 | 0.080 |
Why?
|
Adrenergic beta-Antagonists | 1 | 2015 | 1241 | 0.080 |
Why?
|
Trinucleotide Repeats | 1 | 2010 | 257 | 0.080 |
Why?
|
Lung | 2 | 2018 | 10067 | 0.080 |
Why?
|
Mexico | 1 | 2011 | 770 | 0.080 |
Why?
|
Hypertension | 5 | 2023 | 8616 | 0.080 |
Why?
|
Outpatients | 1 | 2017 | 1596 | 0.080 |
Why?
|
Eyeglasses | 1 | 2010 | 138 | 0.080 |
Why?
|
Allied Health Personnel | 1 | 2010 | 156 | 0.080 |
Why?
|
Antipsychotic Agents | 1 | 2022 | 3078 | 0.080 |
Why?
|
Family Health | 1 | 2013 | 1254 | 0.080 |
Why?
|
Growth Hormone | 1 | 2010 | 572 | 0.080 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 1 | 2015 | 1514 | 0.080 |
Why?
|
Disease Susceptibility | 1 | 2015 | 1791 | 0.080 |
Why?
|
Heart Ventricles | 2 | 2010 | 3832 | 0.070 |
Why?
|
Odds Ratio | 4 | 2017 | 9661 | 0.070 |
Why?
|
Cluster Analysis | 4 | 2021 | 2717 | 0.070 |
Why?
|
Norwood Procedures | 1 | 2010 | 192 | 0.070 |
Why?
|
Regression Analysis | 4 | 2013 | 6329 | 0.070 |
Why?
|
Iron | 2 | 2015 | 1812 | 0.070 |
Why?
|
Thinness | 1 | 2011 | 482 | 0.070 |
Why?
|
Peptide Fragments | 2 | 2017 | 5143 | 0.070 |
Why?
|
Linear Models | 5 | 2019 | 5874 | 0.070 |
Why?
|
Diabetes Mellitus, Type 2 | 4 | 2023 | 12245 | 0.070 |
Why?
|
Cholecalciferol | 1 | 2013 | 550 | 0.070 |
Why?
|
Electroencephalography | 2 | 2022 | 6282 | 0.070 |
Why?
|
Coronary Vessels | 2 | 2016 | 3100 | 0.070 |
Why?
|
Phenotype | 2 | 2023 | 16724 | 0.070 |
Why?
|
Bone Resorption | 1 | 2011 | 721 | 0.070 |
Why?
|
Reproduction | 1 | 2012 | 645 | 0.070 |
Why?
|
Hyperlipidemias | 2 | 2010 | 771 | 0.070 |
Why?
|
Sleep | 1 | 2023 | 4815 | 0.070 |
Why?
|
Compressive Strength | 1 | 2008 | 159 | 0.070 |
Why?
|
Hemoglobins | 3 | 2023 | 1531 | 0.070 |
Why?
|
Parkinson Disease | 1 | 2021 | 2884 | 0.070 |
Why?
|
Poverty | 1 | 2019 | 2714 | 0.070 |
Why?
|
Brazil | 1 | 2011 | 1249 | 0.070 |
Why?
|
Autoantibodies | 1 | 2016 | 2115 | 0.070 |
Why?
|
Adolescent | 15 | 2024 | 88904 | 0.070 |
Why?
|
Population Groups | 1 | 2008 | 209 | 0.070 |
Why?
|
Diffusion Tensor Imaging | 1 | 2017 | 2418 | 0.070 |
Why?
|
Work Capacity Evaluation | 1 | 2006 | 42 | 0.070 |
Why?
|
Psychomotor Performance | 1 | 2015 | 1885 | 0.070 |
Why?
|
Hip | 1 | 2008 | 251 | 0.070 |
Why?
|
Medicare | 2 | 2022 | 6820 | 0.070 |
Why?
|
Physical Endurance | 1 | 2008 | 369 | 0.060 |
Why?
|
Endocrine System | 1 | 2006 | 112 | 0.060 |
Why?
|
Epidemiologic Methods | 2 | 2009 | 1326 | 0.060 |
Why?
|
Urination Disorders | 1 | 2007 | 236 | 0.060 |
Why?
|
Feasibility Studies | 1 | 2017 | 5306 | 0.060 |
Why?
|
Hepatocytes | 1 | 2013 | 1246 | 0.060 |
Why?
|
Heart | 1 | 2019 | 4425 | 0.060 |
Why?
|
Chronic Disease | 2 | 2019 | 9357 | 0.060 |
Why?
|
Exercise Tolerance | 1 | 2010 | 847 | 0.060 |
Why?
|
Down-Regulation | 2 | 2010 | 2931 | 0.060 |
Why?
|
Work | 1 | 2006 | 195 | 0.060 |
Why?
|
Sweden | 2 | 2018 | 1382 | 0.060 |
Why?
|
Cytosine | 1 | 2006 | 212 | 0.060 |
Why?
|
Sensitivity and Specificity | 1 | 2020 | 14652 | 0.060 |
Why?
|
Guanine | 1 | 2006 | 280 | 0.060 |
Why?
|
Likelihood Functions | 1 | 2008 | 993 | 0.060 |
Why?
|
Energy Intake | 3 | 2017 | 2142 | 0.060 |
Why?
|
Hypoplastic Left Heart Syndrome | 1 | 2010 | 595 | 0.060 |
Why?
|
Dehydroepiandrosterone | 1 | 2005 | 249 | 0.060 |
Why?
|
Hip Joint | 1 | 2011 | 1017 | 0.060 |
Why?
|
Blood Pressure | 2 | 2023 | 8533 | 0.060 |
Why?
|
Obesity | 5 | 2023 | 13090 | 0.060 |
Why?
|
Injury Severity Score | 1 | 2008 | 1049 | 0.060 |
Why?
|
Myocardial Infarction | 2 | 2023 | 11513 | 0.060 |
Why?
|
Hypolipidemic Agents | 1 | 2009 | 609 | 0.060 |
Why?
|
Repetitive Sequences, Nucleic Acid | 1 | 2006 | 781 | 0.060 |
Why?
|
Genetic Association Studies | 1 | 2013 | 2746 | 0.060 |
Why?
|
Erythrocytes | 1 | 2013 | 2412 | 0.050 |
Why?
|
Evidence-Based Medicine | 2 | 2020 | 3692 | 0.050 |
Why?
|
Transdermal Patch | 1 | 2023 | 51 | 0.050 |
Why?
|
Prognosis | 3 | 2018 | 29948 | 0.050 |
Why?
|
Enzyme Inhibitors | 1 | 2013 | 3721 | 0.050 |
Why?
|
Estrogen Replacement Therapy | 1 | 2009 | 1205 | 0.050 |
Why?
|
Prenatal Diagnosis | 1 | 2010 | 1271 | 0.050 |
Why?
|
Gene Frequency | 1 | 2010 | 3624 | 0.050 |
Why?
|
Insulin-Like Growth Factor I | 1 | 2010 | 1935 | 0.050 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3110 | 0.050 |
Why?
|
Upper Extremity | 1 | 2008 | 684 | 0.050 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3232 | 0.050 |
Why?
|
Attitude to Health | 1 | 2011 | 2021 | 0.050 |
Why?
|
Safety | 1 | 2007 | 1157 | 0.050 |
Why?
|
Imaging, Three-Dimensional | 1 | 2016 | 4047 | 0.050 |
Why?
|
Delivery of Health Care | 1 | 2020 | 5368 | 0.050 |
Why?
|
Osteocalcin | 2 | 2017 | 271 | 0.050 |
Why?
|
Metabolism | 2 | 2016 | 193 | 0.050 |
Why?
|
Single-Blind Method | 2 | 2017 | 1587 | 0.050 |
Why?
|
Ovariectomy | 2 | 2014 | 612 | 0.050 |
Why?
|
Breast Neoplasms | 1 | 2009 | 21162 | 0.050 |
Why?
|
Atrial Fibrillation | 1 | 2020 | 5182 | 0.050 |
Why?
|
Extremities | 2 | 2017 | 869 | 0.050 |
Why?
|
Quality Improvement | 1 | 2017 | 3850 | 0.050 |
Why?
|
Kidney | 1 | 2017 | 7074 | 0.050 |
Why?
|
Acceleration | 1 | 2022 | 189 | 0.050 |
Why?
|
National Institute on Aging (U.S.) | 1 | 2021 | 40 | 0.050 |
Why?
|
Ventricular Dysfunction, Left | 1 | 2012 | 2143 | 0.050 |
Why?
|
Data Interpretation, Statistical | 2 | 2008 | 2693 | 0.050 |
Why?
|
Hepatitis C | 1 | 2011 | 1595 | 0.050 |
Why?
|
Age Distribution | 3 | 2016 | 2869 | 0.050 |
Why?
|
Heart Function Tests | 2 | 2012 | 316 | 0.050 |
Why?
|
Multilevel Analysis | 1 | 2021 | 148 | 0.050 |
Why?
|
Statistics as Topic | 2 | 2017 | 2351 | 0.050 |
Why?
|
Hemodynamics | 1 | 2011 | 4188 | 0.040 |
Why?
|
Organ Size | 2 | 2017 | 2261 | 0.040 |
Why?
|
Gene Expression Regulation | 3 | 2018 | 11920 | 0.040 |
Why?
|
Adenine | 1 | 2006 | 993 | 0.040 |
Why?
|
Adult Children | 1 | 2020 | 104 | 0.040 |
Why?
|
Anticholesteremic Agents | 1 | 2007 | 970 | 0.040 |
Why?
|
Selection Bias | 1 | 2022 | 359 | 0.040 |
Why?
|
Stroke Volume | 2 | 2012 | 5618 | 0.040 |
Why?
|
Rehabilitation | 1 | 2021 | 129 | 0.040 |
Why?
|
Herpes Zoster | 1 | 2002 | 252 | 0.040 |
Why?
|
Employment | 1 | 2006 | 1110 | 0.040 |
Why?
|
Visual Acuity | 1 | 2010 | 2714 | 0.040 |
Why?
|
Peripheral Arterial Disease | 1 | 2011 | 1304 | 0.040 |
Why?
|
Sex Factors | 3 | 2020 | 10619 | 0.040 |
Why?
|
Tomography, X-Ray Computed | 3 | 2019 | 20708 | 0.040 |
Why?
|
HIV Infections | 2 | 2020 | 17536 | 0.040 |
Why?
|
Men's Health | 1 | 2020 | 75 | 0.040 |
Why?
|
Sexual Behavior | 2 | 2024 | 2192 | 0.040 |
Why?
|
Australia | 2 | 2015 | 1263 | 0.040 |
Why?
|
Purines | 2 | 2013 | 615 | 0.040 |
Why?
|
Housing for the Elderly | 1 | 2019 | 17 | 0.040 |
Why?
|
Blood Pressure Determination | 1 | 2023 | 646 | 0.040 |
Why?
|
Educational Status | 1 | 2007 | 2510 | 0.040 |
Why?
|
Personality Inventory | 1 | 2002 | 1019 | 0.040 |
Why?
|
Collagen Type I | 2 | 2017 | 616 | 0.040 |
Why?
|
Brain | 2 | 2017 | 27159 | 0.040 |
Why?
|
Medical Errors | 1 | 2007 | 1260 | 0.040 |
Why?
|
Insulin | 3 | 2018 | 6608 | 0.040 |
Why?
|
Depressive Disorder, Major | 1 | 2016 | 4810 | 0.040 |
Why?
|
Remote Sensing Technology | 1 | 2019 | 93 | 0.040 |
Why?
|
Pelvic Floor | 1 | 2019 | 138 | 0.040 |
Why?
|
Menopause, Premature | 1 | 2019 | 124 | 0.040 |
Why?
|
Erythrocyte Count | 1 | 2018 | 158 | 0.040 |
Why?
|
Cross-Over Studies | 3 | 2014 | 2108 | 0.040 |
Why?
|
Program Evaluation | 1 | 2007 | 2504 | 0.040 |
Why?
|
Pandemics | 3 | 2023 | 8735 | 0.040 |
Why?
|
Retirement | 1 | 2019 | 198 | 0.040 |
Why?
|
Heart Failure | 1 | 2022 | 11882 | 0.040 |
Why?
|
Ventricular Function, Left | 1 | 2010 | 3935 | 0.040 |
Why?
|
Interleukin-1beta | 1 | 2023 | 1026 | 0.040 |
Why?
|
Education, Medical, Undergraduate | 1 | 2007 | 1087 | 0.040 |
Why?
|
Lung Volume Measurements | 1 | 2018 | 381 | 0.040 |
Why?
|
Patient Acceptance of Health Care | 1 | 2011 | 3230 | 0.040 |
Why?
|
Vitamins | 2 | 2018 | 1631 | 0.030 |
Why?
|
Students, Medical | 2 | 2007 | 1962 | 0.030 |
Why?
|
Supine Position | 1 | 2017 | 208 | 0.030 |
Why?
|
Internship and Residency | 2 | 2007 | 5943 | 0.030 |
Why?
|
Teriparatide | 1 | 2018 | 225 | 0.030 |
Why?
|
Temperature | 1 | 2023 | 2233 | 0.030 |
Why?
|
Procollagen | 1 | 2017 | 189 | 0.030 |
Why?
|
Intelligence Tests | 1 | 2017 | 504 | 0.030 |
Why?
|
Solubility | 1 | 2018 | 1078 | 0.030 |
Why?
|
Chromosomes, Human, X | 1 | 2018 | 319 | 0.030 |
Why?
|
Hyperalgesia | 1 | 2000 | 527 | 0.030 |
Why?
|
Neuralgia | 1 | 2002 | 618 | 0.030 |
Why?
|
Benzodiazepines | 1 | 2022 | 1137 | 0.030 |
Why?
|
Dehydroepiandrosterone Sulfate | 2 | 2007 | 240 | 0.030 |
Why?
|
Ferritins | 1 | 2018 | 601 | 0.030 |
Why?
|
Financing, Government | 1 | 2019 | 473 | 0.030 |
Why?
|
New South Wales | 1 | 2015 | 69 | 0.030 |
Why?
|
Psychiatric Status Rating Scales | 2 | 2016 | 6020 | 0.030 |
Why?
|
Meta-Analysis as Topic | 1 | 2020 | 1365 | 0.030 |
Why?
|
Infection Control | 1 | 2022 | 984 | 0.030 |
Why?
|
Self-Assessment | 1 | 2017 | 400 | 0.030 |
Why?
|
Ankle Joint | 1 | 2019 | 452 | 0.030 |
Why?
|
Internet | 1 | 2007 | 3113 | 0.030 |
Why?
|
Lipids | 2 | 2018 | 3319 | 0.030 |
Why?
|
Feedback, Sensory | 1 | 2014 | 58 | 0.030 |
Why?
|
Pilot Projects | 2 | 2022 | 8728 | 0.030 |
Why?
|
Eflornithine | 1 | 2013 | 31 | 0.030 |
Why?
|
Pain Measurement | 3 | 2017 | 3576 | 0.030 |
Why?
|
Thiamine | 1 | 2015 | 160 | 0.030 |
Why?
|
Anti-Inflammatory Agents | 1 | 2023 | 1805 | 0.030 |
Why?
|
Phosphorus | 1 | 2015 | 336 | 0.030 |
Why?
|
Prostate-Specific Antigen | 1 | 2023 | 2463 | 0.030 |
Why?
|
Ornithine Decarboxylase | 1 | 2013 | 63 | 0.030 |
Why?
|
Primary Health Care | 2 | 2020 | 4735 | 0.030 |
Why?
|
RNA, Viral | 1 | 2022 | 2867 | 0.030 |
Why?
|
Diphosphonates | 1 | 2018 | 625 | 0.030 |
Why?
|
Middle Cerebral Artery | 1 | 2015 | 271 | 0.030 |
Why?
|
Anthropometry | 1 | 2018 | 1336 | 0.030 |
Why?
|
Alkaline Phosphatase | 1 | 2017 | 855 | 0.030 |
Why?
|
beta Carotene | 1 | 2015 | 523 | 0.030 |
Why?
|
Lipoproteins | 1 | 2018 | 871 | 0.030 |
Why?
|
Androstenedione | 1 | 2013 | 138 | 0.030 |
Why?
|
Pain Threshold | 1 | 2017 | 606 | 0.030 |
Why?
|
Diabetes Complications | 2 | 2012 | 1319 | 0.030 |
Why?
|
Pelvis | 1 | 2018 | 737 | 0.030 |
Why?
|
Movement | 1 | 2020 | 1468 | 0.030 |
Why?
|
Sensory Thresholds | 1 | 2014 | 377 | 0.030 |
Why?
|
Blood Flow Velocity | 1 | 2017 | 1374 | 0.030 |
Why?
|
Allosteric Regulation | 1 | 2014 | 425 | 0.030 |
Why?
|
Radioimmunoassay | 1 | 2013 | 861 | 0.030 |
Why?
|
Case-Control Studies | 3 | 2017 | 22248 | 0.030 |
Why?
|
Self Efficacy | 1 | 2017 | 643 | 0.030 |
Why?
|
Orgasm | 1 | 2012 | 62 | 0.030 |
Why?
|
Follistatin | 1 | 2013 | 138 | 0.030 |
Why?
|
Mass Spectrometry | 1 | 2020 | 2198 | 0.030 |
Why?
|
Interviews as Topic | 1 | 2020 | 2741 | 0.030 |
Why?
|
Skilled Nursing Facilities | 1 | 2017 | 406 | 0.030 |
Why?
|
Neoplasms | 2 | 2020 | 22350 | 0.030 |
Why?
|
Premenopause | 1 | 2017 | 1039 | 0.030 |
Why?
|
Penile Erection | 1 | 2012 | 100 | 0.030 |
Why?
|
Smad Proteins | 1 | 2013 | 157 | 0.030 |
Why?
|
Transcranial Magnetic Stimulation | 1 | 2022 | 1498 | 0.030 |
Why?
|
Preventive Health Services | 1 | 2017 | 571 | 0.030 |
Why?
|
Chi-Square Distribution | 2 | 2010 | 3432 | 0.030 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2007 | 3250 | 0.030 |
Why?
|
Sebum | 1 | 2012 | 17 | 0.020 |
Why?
|
Range of Motion, Articular | 1 | 2019 | 1597 | 0.020 |
Why?
|
Respiratory Function Tests | 1 | 2017 | 1691 | 0.020 |
Why?
|
Clinical Trials as Topic | 1 | 2008 | 8045 | 0.020 |
Why?
|
Mendelian Randomization Analysis | 1 | 2018 | 1044 | 0.020 |
Why?
|
Health Services | 1 | 2017 | 755 | 0.020 |
Why?
|
Coitus | 1 | 2012 | 132 | 0.020 |
Why?
|
Vitamin A | 1 | 2015 | 611 | 0.020 |
Why?
|
Transferrin | 1 | 2013 | 283 | 0.020 |
Why?
|
Trauma Centers | 2 | 2008 | 950 | 0.020 |
Why?
|
Analysis of Variance | 2 | 2010 | 6214 | 0.020 |
Why?
|
Retrospective Studies | 5 | 2022 | 81635 | 0.020 |
Why?
|
Magnesium | 1 | 2015 | 815 | 0.020 |
Why?
|
Depressive Disorder | 1 | 2024 | 3715 | 0.020 |
Why?
|
Interdisciplinary Communication | 1 | 2017 | 932 | 0.020 |
Why?
|
Risk | 2 | 2017 | 9602 | 0.020 |
Why?
|
K562 Cells | 1 | 2013 | 645 | 0.020 |
Why?
|
Plasminogen Activator Inhibitor 1 | 1 | 2012 | 279 | 0.020 |
Why?
|
Survival Analysis | 2 | 2018 | 10100 | 0.020 |
Why?
|
Zinc | 1 | 2015 | 675 | 0.020 |
Why?
|
Prefrontal Cortex | 1 | 2021 | 2224 | 0.020 |
Why?
|
Hypophysectomy | 1 | 2010 | 114 | 0.020 |
Why?
|
Peptides | 2 | 2017 | 4344 | 0.020 |
Why?
|
Mice, Transgenic | 2 | 2013 | 9547 | 0.020 |
Why?
|
Hematocrit | 1 | 2012 | 622 | 0.020 |
Why?
|
Soybean Proteins | 1 | 2010 | 55 | 0.020 |
Why?
|
Smoking | 2 | 2020 | 9077 | 0.020 |
Why?
|
Antidepressive Agents | 1 | 2002 | 2903 | 0.020 |
Why?
|
Knee Joint | 1 | 2019 | 1682 | 0.020 |
Why?
|
Parathyroid Hormone | 1 | 2017 | 1791 | 0.020 |
Why?
|
Interpersonal Relations | 1 | 2017 | 1432 | 0.020 |
Why?
|
Inflammation Mediators | 1 | 2018 | 1889 | 0.020 |
Why?
|
Urban Health | 1 | 2012 | 532 | 0.020 |
Why?
|
Nutritional Status | 1 | 2018 | 1621 | 0.020 |
Why?
|
Urban Population | 1 | 2017 | 2040 | 0.020 |
Why?
|
Biomedical Research | 1 | 2024 | 3459 | 0.020 |
Why?
|
Epigenesis, Genetic | 1 | 2022 | 3824 | 0.020 |
Why?
|
Ethanol | 1 | 2015 | 1326 | 0.020 |
Why?
|
Observer Variation | 1 | 2015 | 2614 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 2 | 2010 | 6512 | 0.020 |
Why?
|
Fibrinogen | 1 | 2012 | 893 | 0.020 |
Why?
|
Orchiectomy | 1 | 2010 | 465 | 0.020 |
Why?
|
Hospitals | 1 | 2022 | 3888 | 0.020 |
Why?
|
Parents | 1 | 2022 | 3593 | 0.020 |
Why?
|
Receptor, IGF Type 1 | 1 | 2010 | 385 | 0.020 |
Why?
|
Arousal | 1 | 2014 | 1174 | 0.020 |
Why?
|
Brain Concussion | 1 | 2019 | 1431 | 0.020 |
Why?
|
Polymorphism, Single Nucleotide | 2 | 2018 | 16044 | 0.020 |
Why?
|
DNA Methylation | 1 | 2022 | 4427 | 0.020 |
Why?
|
Bone Morphogenetic Proteins | 1 | 2013 | 844 | 0.020 |
Why?
|
Anastomosis, Surgical | 1 | 2011 | 992 | 0.020 |
Why?
|
Intraoperative Care | 1 | 2011 | 768 | 0.020 |
Why?
|
Patient Compliance | 1 | 2017 | 2694 | 0.020 |
Why?
|
Injections | 1 | 2010 | 839 | 0.020 |
Why?
|
Waist-Hip Ratio | 1 | 2008 | 521 | 0.020 |
Why?
|
Cholesterol | 1 | 2016 | 2903 | 0.020 |
Why?
|
Sampling Studies | 1 | 2008 | 614 | 0.020 |
Why?
|
Fatty Liver | 1 | 2013 | 810 | 0.020 |
Why?
|
Child | 5 | 2012 | 80668 | 0.020 |
Why?
|
Secondary Prevention | 1 | 2012 | 1469 | 0.020 |
Why?
|
Algorithms | 2 | 2016 | 14072 | 0.020 |
Why?
|
Postoperative Period | 1 | 2010 | 1824 | 0.020 |
Why?
|
Health Status Disparities | 1 | 2017 | 1880 | 0.020 |
Why?
|
Anxiety | 1 | 2020 | 4670 | 0.020 |
Why?
|
Pulmonary Veins | 1 | 2011 | 758 | 0.020 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2013 | 3796 | 0.020 |
Why?
|
California | 1 | 2009 | 1435 | 0.020 |
Why?
|
Postmenopause | 1 | 2014 | 2517 | 0.020 |
Why?
|
Heart Atria | 1 | 2011 | 1361 | 0.020 |
Why?
|
Multicenter Studies as Topic | 1 | 2010 | 1733 | 0.020 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2018 | 3359 | 0.010 |
Why?
|
Polypharmacy | 1 | 2007 | 307 | 0.010 |
Why?
|
Kinetics | 1 | 2012 | 6287 | 0.010 |
Why?
|
Recombinant Proteins | 1 | 2013 | 6507 | 0.010 |
Why?
|
Patient Discharge | 1 | 2017 | 3465 | 0.010 |
Why?
|
Epidemiologic Studies | 1 | 2007 | 677 | 0.010 |
Why?
|
Gene Expression | 1 | 2016 | 7585 | 0.010 |
Why?
|
Electrocardiography | 1 | 2017 | 6408 | 0.010 |
Why?
|
Risk Management | 1 | 2007 | 558 | 0.010 |
Why?
|
Demography | 1 | 2008 | 1641 | 0.010 |
Why?
|
Natriuretic Peptide, Brain | 1 | 2012 | 1750 | 0.010 |
Why?
|
Genotype | 1 | 2018 | 13036 | 0.010 |
Why?
|
Proportional Hazards Models | 2 | 2009 | 12534 | 0.010 |
Why?
|
Sex Distribution | 1 | 2008 | 2274 | 0.010 |
Why?
|
Knee | 1 | 2004 | 274 | 0.010 |
Why?
|
Drug Therapy, Combination | 1 | 2012 | 6307 | 0.010 |
Why?
|
Heart Rate | 1 | 2014 | 4207 | 0.010 |
Why?
|
Drug Administration Schedule | 1 | 2010 | 4853 | 0.010 |
Why?
|
Calcium | 1 | 2015 | 5783 | 0.010 |
Why?
|
Sickness Impact Profile | 1 | 2002 | 299 | 0.010 |
Why?
|
RNA, Small Interfering | 1 | 2010 | 3425 | 0.010 |
Why?
|
Mice | 3 | 2013 | 81889 | 0.010 |
Why?
|
Residence Characteristics | 1 | 2011 | 2116 | 0.010 |
Why?
|
Stroke | 1 | 2023 | 9741 | 0.010 |
Why?
|
Mass Screening | 1 | 2016 | 5454 | 0.010 |
Why?
|
Radiography | 1 | 2011 | 6968 | 0.010 |
Why?
|
Schools, Medical | 1 | 2007 | 882 | 0.010 |
Why?
|
Educational Measurement | 1 | 2007 | 1259 | 0.010 |
Why?
|
Signal Transduction | 2 | 2013 | 23619 | 0.010 |
Why?
|
Statistics, Nonparametric | 1 | 2005 | 2846 | 0.010 |
Why?
|
Social Class | 1 | 2009 | 2007 | 0.010 |
Why?
|
Factor Analysis, Statistical | 1 | 2002 | 1001 | 0.010 |
Why?
|
Pain | 1 | 2015 | 5098 | 0.010 |
Why?
|
Alcohol Drinking | 1 | 2012 | 4045 | 0.010 |
Why?
|
Rats, Sprague-Dawley | 1 | 2010 | 8106 | 0.010 |
Why?
|
Capsaicin | 1 | 2000 | 233 | 0.010 |
Why?
|
Transcription, Genetic | 1 | 2013 | 7609 | 0.010 |
Why?
|
Ultrasonography | 1 | 2012 | 5992 | 0.010 |
Why?
|
Forecasting | 1 | 2008 | 2936 | 0.010 |
Why?
|
Physical Stimulation | 1 | 2000 | 514 | 0.010 |
Why?
|
Injections, Subcutaneous | 1 | 2000 | 684 | 0.010 |
Why?
|
Genome-Wide Association Study | 1 | 2018 | 12806 | 0.010 |
Why?
|
Patient Selection | 1 | 2010 | 4252 | 0.010 |
Why?
|
Learning | 1 | 2007 | 1754 | 0.010 |
Why?
|
Medically Uninsured | 1 | 2002 | 838 | 0.010 |
Why?
|
Diet | 1 | 2015 | 8088 | 0.010 |
Why?
|
Population Surveillance | 1 | 2007 | 2594 | 0.010 |
Why?
|
Models, Theoretical | 1 | 2008 | 3561 | 0.010 |
Why?
|
Animals | 3 | 2013 | 168930 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2013 | 22352 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2010 | 18984 | 0.010 |
Why?
|
Electronic Health Records | 1 | 2012 | 4880 | 0.010 |
Why?
|
Decision Making | 1 | 2008 | 3951 | 0.010 |
Why?
|
Rats | 1 | 2010 | 23717 | 0.010 |
Why?
|
Heart Diseases | 1 | 2006 | 2817 | 0.010 |
Why?
|
Social Support | 1 | 2002 | 2191 | 0.010 |
Why?
|
Health Behavior | 1 | 2002 | 2649 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2010 | 26389 | 0.010 |
Why?
|
Child, Preschool | 1 | 2012 | 42577 | 0.010 |
Why?
|
Pregnancy | 1 | 2010 | 30237 | 0.000 |
Why?
|